These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9144358)

  • 21. Allosensitisation in NHP results in cross-reactive anti-SLA antibodies not detected by a lymphocyte-based flow cytometry crossmatch.
    Ladowski JM; Chapman H; DeLaura I; Anwar IJ; Yoon J; Chen Z; Clark A; Chen D; Knechtle S; Jackson A; Rogers B; Kwun J
    HLA; 2024 Jul; 104(1):e15599. PubMed ID: 39041289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies.
    Sumitran-Karuppan S
    Transplantation; 1999 Aug; 68(4):502-9. PubMed ID: 10480407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches.
    Caro-Oleas JL; González-Escribano MF; Toro-Llamas S; Acevedo MJ; Martinez-Bravo MJ; Aguilera I; Núñez-Roldán A
    Tissue Antigens; 2010 Nov; 76(5):398-403. PubMed ID: 20630037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of panel reactive antibodies in patients requiring kidney transplantation.
    Mishra MN; Baliga KV
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):495-9. PubMed ID: 23640620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplantation; 1986 Dec; 42(6):608-13. PubMed ID: 3538548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
    Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
    Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
    Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multilaboratory evaluation of serum analysis for HLA antibody and crossmatch reactivity by lymphocytotoxicity methods.
    Duquesnoy RJ; Marrari M
    Arch Pathol Lab Med; 2003 Feb; 127(2):149-56. PubMed ID: 12562227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.
    Gao B; Rong C; Porcheray F; Moore C; Girouard TC; Saidman SL; Wong W; Fu Y; Zorn E
    Transplantation; 2016 Jan; 100(1):217-26. PubMed ID: 26285015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.
    Imoto S; Kawamura K; Tokumine Y; Araki N; Akita S; Nishimura C; Inaba H; Saigo K; Mabuchi O; Okazaki H
    Transfus Med; 2010 Apr; 20(2):95-103. PubMed ID: 19883399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of antibody monitoring system with flow cytometric crossmatch test in renal transplant recipients with high panel-reactive antibody.
    Hwang HS; Hyoung BJ; Lee SY; Jeon YJ; Yoon HE; Kim JY; Choi BS; Oh EJ; Kim YS; Bang BK; Yang CW
    Nephron Clin Pract; 2009; 111(4):c260-4. PubMed ID: 19293595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Most Common HLA Alleles and Anti-HLA Antibodies to Know for Virtual Cross-Match.
    Baştürk B; Kantaroğlu B; Kavuzlu M; Sarıtürk Ç
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):53-55. PubMed ID: 27805512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histocompatibility testing for highly sensitized transplant candidates.
    Saidman SL
    Transplant Proc; 2007 Apr; 39(3):673-5. PubMed ID: 17445570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.